Pharmafile Logo
Pharmafocus logo
Advanced Search

Mylan to restructure and slash around 10% of workforce

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …

News

BMS shares promising Opdivo/Yervoy data for advanced bladder cancer

December 8, 2016
Research and Development BMS, Yervoy, opdivo

BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …

News
shutterstock_212432119

New Alzheimer’s research edges closer to treatment & prevention

December 7, 2016
Research and Development Alzheimer's

A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …

News

AbbVie links up with Johns Hopkins University in cancer research

December 7, 2016
Medical Communications

AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …

News
lisa_anson

AstraZeneca’s Lisa Anson appointed president of ABPI

December 7, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …

Appointment
imbruv_pack

Janssen reveals positive results from longest follow-up of Imbruvica

December 7, 2016
Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica

Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …

News
jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016
Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

News

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016
Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …

News
astrazeneca_sign_sky

AZ lung cancer drug cuts disease progression by 70%

December 7, 2016
Research and Development AstraZeneca, Tagrisso

AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …

News
veeva_commercial_summit

Veeva releases key details from European Life Sciences Survey

December 6, 2016
veeva

Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …

News
shire_image

Shire given permission for $400 million biologics manufacturing facility

December 6, 2016
Manufacturing and Production, Research and Development Co Meat, Ireland, Shire

Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …

News
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …

Appointment
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

Appointment
gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016
Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …

News
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

News
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …

Appointment
merck_kapa_biosystems

Merck and Roche extend distribution ties

December 5, 2016
Manufacturing and Production Merck, Roche, distribution

Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …

News
entrance_takeda_i020_v1

Takeda to invest €40m in Dublin operations expansion

December 5, 2016
Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda

Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …

News

Mission Therapeutics announces new non-executive chairman

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …

Appointment
interactions-carousel

Scientists create ‘map of drugs’ to aid further development

December 5, 2016
Manufacturing and Production, Medical Communications

Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026